Monocyte activation test (MAT): Insight into examining regulations and markets prospects
Watch this webinar to learn about the current regulations on the monocyte activation test (MAT) and the new type of MAT entering the markets.
Implementation of the monocyte activation test (MAT) is gaining increasing importance in Europe. Find out about the regulatory considerations in the MAT market, as well as product availability and how to determine the most suitable MAT approach for your needs. This webinar will explore answers to key questions, including:
- Why does MAT have such a high relevance in Europe? Who is affected?
- What is the current development in worldwide pharmacopoeias regarding MAT?
- How should MAT be performed according to Ph. Eur.?
The session will also highlight the alternative MAT assay to the ELISA-based MAT, which has risen in popularity. Benefits of this alternative, such as addressing current customer needs on the market (e.g. less lot-to-lot- variation, stable supply chain and shorter assay time) will also be part of the discussion.
Key learning points:
- Understand the relevance of MAT implementation in EU
- Learn about the current status of the MAT in the different pharmacopoeia (USP, EP, JP, ChP)
- Find out how to perform a MAT assay, based on current guidelines
- Discover what the new MAT assay can offer, such as improving time management and more.